2.8400
+0.2900
+(11.37%)
At close: April 17 at 4:00:00 PM EDT
2.7100
-0.13
(-4.58%)
After hours: April 17 at 7:06:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
10,803
10,803
22,271
22,603
17,934
Operating Income
-10,803
-10,803
-22,271
-22,603
-17,934
Net Non Operating Interest Income Expense
-212
-212
-1,707
536
241
Other Income Expense
3,736
3,736
4,001
307
-133
Pretax Income
-7,279
-7,279
-19,977
-21,760
-17,826
Net Income Common Stockholders
-7,240
-7,240
-19,880
-21,668
-18,384
Diluted NI Available to Com Stockholders
-7,240
-7,240
-19,880
-21,668
-18,384
Basic EPS
-44.16
-44.16
-17.96
-23.97
-21.00
Diluted EPS
-49.90
-49.90
-17.96
-23.97
-21.00
Basic Average Shares
163.9570
163.9570
1,106.6650
904.0540
878.4020
Diluted Average Shares
163.9790
163.9790
1,106.6650
904.0540
878.4020
Total Operating Income as Reported
-11,005
-11,005
-22,271
-22,603
-17,934
Total Expenses
10,803
10,803
22,271
22,603
17,934
Net Income from Continuing & Discontinued Operation
-7,240
-7,240
-19,880
-21,668
-18,384
Normalized Income
-10,976
-10,976
-23,881
-21,975
-17,609
Interest Income
260
260
474
532
320
Interest Expense
41
41
56
67
79
Net Interest Income
-212
-212
-1,707
536
241
EBIT
-7,238
-7,238
-19,921
-21,693
-17,747
EBITDA
-7,052
-7,052
-19,724
-21,492
-17,516
Reconciled Depreciation
186
186
197
201
231
Net Income from Continuing Operation Net Minority Interest
-7,240
-7,240
-19,880
-21,668
-17,742
Total Unusual Items Excluding Goodwill
3,736
3,736
4,001
307
-133
Total Unusual Items
3,736
3,736
4,001
307
-133
Normalized EBITDA
-10,788
-10,788
-23,725
-21,799
-17,383
12/31/2021 - 11/20/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNTI Senti Biosciences, Inc.
3.8800
+4.02%
CANF Can-Fite BioPharma Ltd.
1.2000
-2.44%
GNTA Genenta Science S.p.A.
3.8800
+4.30%
RNTX Rein Therapeutics Inc.
1.7000
+3.03%
PHGE BiomX Inc.
0.5397
-0.11%
TTNP Titan Pharmaceuticals, Inc.
3.7300
+3.04%
ENTX Entera Bio Ltd.
1.7900
+1.70%
ORMP Oramed Pharmaceuticals Inc.
2.1500
-2.27%
VERA Vera Therapeutics, Inc.
21.29
+0.24%
BLRX BioLineRx Ltd.
2.8800
+3.97%